Magnetic brain stimulation before behavior therapy for adults with Tourette syndrome
Tests magnetic brain stimulation before tic therapy in adults with Tourette syndrome.
Key facts
- Who runs it
- West Virginia University
- Where
- Morgantown, United StatesSee the site
- Trial code
- Registry title
- Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 12 Mar 2024
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- transcranial magnetic stimulation
- Record updated
- 18 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Tourette Syndrome whose tics are moderate. They get real or sham (fake) magnetic brain stimulation, then 8 sessions of behavioral therapy for tics (CBIT).
- Age
- 18 years or older (up to 100 years)
- Sex
- All sexes can join
- Disease stage
- Diagnosis of Tourette Syndrome with moderate tic severity at the start
Main reasons for not taking part
- Metal objects or nerve stimulators in the brain
- Pregnancy
- Active seizures or epilepsy in the past
- Cannot have an fMRI brain scan
- Other mental or medical conditions that prevent taking part in CBIT
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 18 years or older
- Diagnosis of Tourette Syndrome
- Moderate Tic Severity at baseline
Who cannot take part
- Contraindications to receiving fMRI
- History of active seizures or epilepsy
- Inability to participate in CBIT due to other underlying cognitive or medical condition
- Presence of metallic objects or neurostimulators in the brain
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in United States
- WVU RNIMorgantown, United StatesContact: Jessica Frey, MDTaking people
About the trial
What the trial wants to find out
This pilot study will investigate the clinical and neurophysiological effects of repetitive transcranial magnetic stimulation (rTMS) followed by comprehensive behavioral intervention for tics (CBIT) in adult patients with Tourette's Syndrome (TS). Two groups of moderate disease severity will be randomized to receive active or sham rTMS targeted to the supplementary motor area (SMA) followed by eight CBIT sessions. The change in tic frequency and severity (primary outcome) and neurophysiological changes (secondary outcome) will be compared between the two groups. The central hypothesis is that low frequency rTMS will augment the effects of CBIT through favorable priming of the SMA network.
The 2 groups in the trial
- Active rTMSExisting treatment, for comparison
Patients receiving active rTMS
Treatment: transcranial magnetic stimulation
- Sham rTMSSham treatment, for comparison
Patients receiving sham rTMS
Treatment: transcranial magnetic stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
- Plain-language title
- Magnetic brain stimulation before behavior therapy for adults with Tourette syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05705999, who can take part
- Record updated
- 18 July 2025